Literature DB >> 23932389

18F-FDG PET/CT in suspected recurrences of epithelial malignant pleural mesothelioma in asbestos-fibers-exposed patients (comparison to standard diagnostic follow-up).

Artor Niccoli-Asabella1, Antonio Notaristefano, Domenico Rubini, Corinna Altini, Cristina Ferrari, Nunzio Merenda, Margherita Fanelli, Giuseppe Rubini.   

Abstract

This retrospective study evaluated the role of 18-fluorine-labeled 2-deoxy-2-fluoro-D-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) in patients with previous occupational or environmental exposure to asbestos, with histopathological diagnosis of epithelial malignant pleural mesothelioma and suspected recurrences, comparing the data from 18F-FDG PET/CT and computed tomography with contrast enhancement (CECT). 18F-FDG PET/CT has greater sensitivity than CECT in identifying local extent, lymph nodes, and metastasis. 18F-FDG PET/CT whole-body explorations are useful to monitor the follow-up and evaluate the metabolic response to chemo- and radiotherapy, modifying the scheduled treatment plan.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  18F-FDG PET/CT; Asbestos fibers; CECT; Pleural mesothelioma

Mesh：

Substances：

Year:  2013        PMID： 23932389     DOI： 10.1016/j.clinimag.2013.06.009

Source DB:  PubMed          Journal:  Clin Imaging        ISSN： 0899-7071            Impact factor:   1.605


  8 in total

Review 1.  Management of metastatic retroperitoneal sarcoma: a consensus approach from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG).

Authors: 
Journal:  Ann Oncol       Date:  2018-04-01       Impact factor: 32.976

2.  Systemic Therapy Use and Outcomes After Relapse from Preoperative Radiation and Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma.

Authors:  Sara V Soldera; John Kavanagh; Melania Pintilie; Natasha B Leighl; Marc de Perrot; John Cho; Andrew Hope; Ronald Feld; Penelope A Bradbury
Journal:  Oncologist       Date:  2018-11-26

Review 3.  Role of chest computed tomography in prevention of occupational respiratory disease: review of recent literature.

Authors:  David N Weissman
Journal:  Semin Respir Crit Care Med       Date:  2015-05-29       Impact factor: 3.119

Review 4.  Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.

Authors:  Kazuhiro Kitajima; Hiroshi Doi; Kozo Kuribayashi
Journal:  Jpn J Radiol       Date:  2016-05-24       Impact factor: 2.374

5.  Malignant pleural and peritoneal mesothelioma consequential to brief indirect asbestos exposure.

Authors:  Bharati Singhal; Supreethi Kohli; Anu Singhal; Vinod Kumar
Journal:  J Clin Imaging Sci       Date:  2014-06-30

Review 6.  Tyrosine-Kinase Inhibitors Therapies with Mainly Anti-Angiogenic Activity in Advanced Renal Cell Carcinoma: Value of PET/CT in Response Evaluation.

Authors:  Girolamo Ranieri; Ilaria Marech; Artor Niccoli Asabella; Alessandra Di Palo; Mariangela Porcelli; Valentina Lavelli; Giuseppe Rubini; Cristina Ferrari; Cosmo Damiano Gadaleta
Journal:  Int J Mol Sci       Date:  2017-09-09       Impact factor: 5.923

Review 7.  Clinical staging of malignant pleural mesothelioma: current perspectives.

Authors:  Maria Bonomi; Costantino De Filippis; Egesta Lopci; Letizia Gianoncelli; Giovanna Rizzardi; Eleonora Cerchiaro; Luigi Bortolotti; Alessandro Zanello; Giovanni Luca Ceresoli
Journal:  Lung Cancer (Auckl)       Date:  2017-08-18

8.  Clinical utility of FDG-PET/CT for post-surgery surveillance of malignant pleural mesothelioma - Comparison with contrast-enhanced CT.

Authors:  Kazuhiro Kitajima; Masaki Hashimoto; Takayuki Katsuura; Nobuyuki Kondo; Toshiyuki Minami; Kozo Kuribayashi; Seiki Hasegawa; Takashi Kijima; Koichiro Yamakado
Journal:  Oncotarget       Date:  2019-11-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.